• A Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of LY3537031 in Adults with Irritable Bowel Syndrome‑Diarrhea (IBS‑D)

    Recruiting

    2 1
    Investigated Drugs:
    Belgium Germany Poland Spain

  • Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Greece Italy Lithuania Norway +4

  • Phase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)

    Recruiting

    2 1
    Denmark Germany The Netherlands Spain

  • Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Hungary Latvia Lithuania Poland Slovakia +1

  • A study to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight and type 2 diabetes

    Recruiting

    3 1
    Investigated Drugs:
    Czechia Germany Poland Slovakia Spain

  • Safety and dose‑finding study of trazodone hydrochloride and psilocybin in patients with treatment‑resistant depression

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Italy

  • Study of mirikizumab and tirzepatide for adults with moderate to severe Crohn’s disease who are overweight or obese

    Recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Efficacy and Safety of Brenipatide (LY3537031) in Adults with Irritable Bowel Syndrome‑Constipation (IBS‑C) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Spain

  • Study of MK-1084 and Pembrolizumab for First-Line Treatment in Patients with Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation and High PD-L1 Levels

    Recruiting

    3 1 1
    Investigated Drugs:
    Austria Bulgaria France Germany Greece Italy +4

  • Tezepelumab Effects on TSLP Protein Induction in Adults with Severe Asthma, With and Without Chronic Rhinosinusitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Denmark

powered by